Cargando…

Management of Residual Risk in Chronic Coronary Syndromes. Clinical Pathways for a Quality-Based Secondary Prevention

Chronic coronary syndrome (CCS), which encompasses a broad spectrum of clinical presentations of coronary artery disease (CAD), is the leading cause of morbidity and mortality worldwide. Recent guidelines for the management of CCS emphasize the dynamic nature of the CAD process, replacing the term “...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giubilato, Simona, Lucà, Fabiana, Abrignani, Maurizio Giuseppe, Gatto, Laura, Rao, Carmelo Massimiliano, Ingianni, Nadia, Amico, Francesco, Rossini, Roberta, Caretta, Giorgio, Cornara, Stefano, Di Matteo, Irene, Di Nora, Concetta, Favilli, Silvia, Pilleri, Anna, Pozzi, Andrea, Temporelli, Pier Luigi, Zuin, Marco, Amico, Antonio Francesco, Riccio, Carmine, Grimaldi, Massimo, Colivicchi, Furio, Oliva, Fabrizio, Gulizia, Michele Massimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531720/ https://www.ncbi.nlm.nih.gov/pubmed/37762932 http://dx.doi.org/10.3390/jcm12185989

Ejemplares similares

A Tailored Antithrombotic Approach for Patients with Atrial Fibrillation Presenting with Acute Coronary Syndrome and/or Undergoing PCI: A Case Series
por: Giubilato, Simona, et al.
Publicado: (2022)

Appropriateness of Dyslipidemia Management Strategies in Post-Acute Coronary Syndrome: A 2023 Update
por: Lucà, Fabiana, et al.
Publicado: (2023)

Management of oral anticoagulant therapy after intracranial hemorrhage in patients with atrial fibrillation
por: Lucà, Fabiana, et al.
Publicado: (2023)

Management of Patients Treated with Direct Oral Anticoagulants in Clinical Practice and Challenging Scenarios
por: Lucà, Fabiana, et al.
Publicado: (2023)

ANMCO/GICR-IACPR/SICI-GISE Consensus Document: the clinical management of chronic ischaemic cardiomyopathy
por: Riccio, Carmine, et al.
Publicado: (2017)

Characteristics, treatment and quality of life of stable coronary artery disease patients with or without angina: Insights from the START study
por: De Luca, Leonardo, et al.
Publicado: (2018)

Reply to Kielb et al. Untapped Potential for Female Patients? Comment on “Lucà et al. Update on Management of Cardiovascular Diseases in Women. J. Clin. Med. 2022, 11, 1176”
por: Lucà, Fabiana, et al.
Publicado: (2022)

ANMCO Position Paper: diagnostic–therapeutic pathway in patients with hypercholesterolaemia and statin intolerance
por: Gulizia, Michele Massimo, et al.
Publicado: (2017)

ANMCO Scientific Statement: clinical management of hypercholesterolaemia in patients with acute coronary syndromes
por: Colivicchi, Furio, et al.
Publicado: (2017)

The role of the pregnancy heart team in clinical practice
por: Lucà, Fabiana, et al.
Publicado: (2023)

Update on Management of Cardiovascular Diseases in Women
por: Lucà, Fabiana, et al.
Publicado: (2022)

Management of Acute Coronary Syndrome in Cancer Patients: It’s High Time We Dealt with It
por: Lucà, Fabiana, et al.
Publicado: (2022)

ANMCO Position Paper: direct oral anticoagulants for stroke prevention in atrial fibrillation: clinical scenarios and future perspectives
por: Nardi, Federico, et al.
Publicado: (2017)

COVID-19, Vaccines, and Thrombotic Events: A Narrative Review
por: Abrignani, Maurizio G., et al.
Publicado: (2022)

Clinical Impact and Prognostic Role of Triglyceride to High-Density Lipoprotein Cholesterol Ratio in Patients With Chronic Coronary Syndromes at Very High Risk: Insights From the START Study
por: De Luca, Leonardo, et al.
Publicado: (2022)

ANMCO Position Paper: hospital discharge planning: recommendations and standards
por: Mennuni, Mauro, et al.
Publicado: (2017)

ANMCO-SIMEU consensus document: appropriate management of atrial fibrillation in the emergency department
por: Caldarola, Pasquale, et al.
Publicado: (2023)

Anticoagulation in Atrial Fibrillation Cardioversion: What Is Crucial to Take into Account
por: Lucà, Fabiana, et al.
Publicado: (2021)

Patent Foramen Ovale and Cryptogenic Stroke: Integrated Management
por: Lucà, Fabiana, et al.
Publicado: (2023)

ANMCO position paper: 2022 focused update of appropriate use criteria for multimodality imaging: aortic valve disease
por: Nardi, Federico, et al.
Publicado: (2022)

Direct Oral Anticoagulants in Patients with Obesity and Atrial Fibrillation: Position Paper of Italian National Association of Hospital Cardiologists (ANMCO)
por: Mocini, David, et al.
Publicado: (2021)

Incidence, Characteristics, and Management of Patients with Recurrent Myocardial Infarctions: Insights from the EYESHOT POST-MI
por: De Luca, Leonardo, et al.
Publicado: (2022)

Lipid Lowering Treatment and Eligibility for PCSK9 Inhibition in Post-Myocardial Infarction Patients in Italy: Insights from Two Contemporary Nationwide Registries
por: Colivicchi, Furio, et al.
Publicado: (2020)

Impact of Working from Home on Cardiovascular Health: An Emerging Issue with the COVID-19 Pandemic
por: Di Fusco, Stefania Angela, et al.
Publicado: (2021)

Italian Association of Hospital Cardiologists practical guidance for sodium–glucose cotransporter 2 inhibitors use in patients with heart failure
por: Di Fusco, Stefania Angela, et al.
Publicado: (2023)

ANMCO POSITION PAPER: Prognostic and therapeutic relevance of non-obstructive coronary atherosclerosis
por: Casolo, Giancarlo, et al.
Publicado: (2021)

ANMCO POSITION PAPER: Use of sacubitril/valsartan in hospitalized patients with acute heart failure
por: Di Tano, Giuseppe, et al.
Publicado: (2021)

Clinical Utility of Three-Dimensional Echocardiography in the Evaluation of Mitral Valve Disease: Tips and Tricks
por: Pino, Paolo G., et al.
Publicado: (2023)

BLITZ‐HF: a nationwide initiative to evaluate and improve adherence to acute and chronic heart failure guidelines
por: Gulizia, Michele Massimo, et al.
Publicado: (2022)

Clinical pathways and management of antithrombotic therapy in patients with acute coronary syndrome (ACS): a Consensus Document from the Italian Association of Hospital Cardiologists (ANMCO), Italian Society of Cardiology (SIC), Italian Society of Emergency Medicine (SIMEU) and Italian Society of Interventional Cardiology (SICI-GISE)
por: De Luca, Leonardo, et al.
Publicado: (2017)

ANMCO position paper on the management of hypercholesterolaemia in patients with acute coronary syndrome
por: De Luca, Leonardo, et al.
Publicado: (2023)

Screening and management of dyslipidemia in oncologic patients undergoing cardiotoxic therapies: results from an Italian survey
por: Camilli, Massimiliano, et al.
Publicado: (2023)

Clinical Implications of Switching Lipid Lowering Treatment from Rosuvastatin to Other Agents in Primary Care
por: Colivicchi, Furio, et al.
Publicado: (2016)

Type of hospitalisations and in-hospital outcomes in the Italian coronary care unit network at the time of COVID-19 pandemic: the BLITZ-COVID19 Registry
por: Gulizia, Michele Massimo, et al.
Publicado: (2022)

Electrocardiographic characteristics, anthropometric features, and cardiovascular risk factors in a large cohort of adolescents
por: Santini, Massimo, et al.
Publicado: (2018)

Superiority of Direct Oral Anticoagulants over Vitamin K Antagonists in Oncological Patients with Atrial Fibrillation: Analysis of Efficacy and Safety Outcomes
por: Parrini, Iris, et al.
Publicado: (2022)

ANMCO position paper ‘Appropriateness of prescribing direct oral anticoagulants in stroke and systemic thromboembolism prevention in adult patients with non-valvular atrial fibrillation’
por: Mocini, David, et al.
Publicado: (2022)

Remote monitoring: Doomed to let down or an attractive promise?
por: Lucà, Fabiana, et al.
Publicado: (2019)

Lipoprotein (a), Inflammation, and Atherosclerosis
por: Di Fusco, Stefania Angela, et al.
Publicado: (2023)

The Impact of the Coronavirus Disease-2019 Pandemic and Italian Lockdown Measures on Clinical Presentation and Management of Acute Heart Failure
por: Colivicchi, Furio, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_feeffij2af8m5shim2kh3v4o7a